Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction

NCT06576921 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Stomach Neoplasms
Immune Checkpoint Inhibitors

Interventions

DRUG: Serplulimab Combined With Chemotherapy
DRUG: Placebo combined with Chemotherapy

Sponsor

Xijing Hospital

Collaborators

[object Object]
[object Object]
[object Object]